Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
SLC34A3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 95 | 95 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Bone Fragility and Fracture Panel PreventionGenetics United States | 87 | 74 |
|
Nephrolithiasis and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Nephrolithiasis and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Invitae United States | 66 | 40 |
|
Invitae Hypophosphatemia Panel Invitae United States | 23 | 17 |
|
Hypophosphatemic Rickets with Hypercalciuria via the SLC34A3 Gene PreventionGenetics United States | 1 | 1 |
|
Nephrolithiasis and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Nephrolithiasis and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Hypophosphatasia (HPP) and Inherited Hypophosphatemic Rickets Panel PreventionGenetics United States | 20 | 11 |
|
Osteogenesis Imperfecta, Hypophosphatasia (HPP), and Inherited Hypophosphatemic Rickets Panel PreventionGenetics United States | 46 | 37 |
|
Invitae Osteogenesis Imperfecta and Bone Fragility Panel Invitae United States | 120 | 65 |
|
Nephrolithiasis and Nephrocalcinosis Panel PreventionGenetics United States | 33 | 30 |
|
Osteogenesis Imperfecta and Decreased Bone Density NGS Panel Fulgent Genetics United States | 111 | 32 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.